2017 has turned out to be a mixed bag for the pound against the Euro. The shoots of recovery were present in Spring, when Sterling traded at its highest since December, within touching distance of post EU referendum highs. Despite continued strength against the US dollar, the pound has since struggled against its European counterpart….

So much for the summer lull. Over the past few weeks, markets have been spiced up by a multitude of UK companies issuing profits warnings leading to some impressive share price movements. Investors have enjoyed a wild ride, with ample opportunity for impressive share price returns. However, far from being a signal of tougher times,…

2017 has been challenging for many UK pharmaceutical companies; with competition to pump out the most effective, cheapest and easiest to produce drugs at an all-time high, some UK Pharmas are feeling the pressure. However, after tough times often comes great opportunity. This report covers the two largest UK pharmaceutical companies, AstraZeneca and GlaxoSmithKline, analysing…

When markets are ‘quiet’, even the biggest global investment banks can find it tough as markets essentially move sideways over a period of weeks, months or even a full quarter. However, the humble day trader can still capitalise on this using the multitude of smaller, more frequent share price moves to turn an impressive profit….

With earnings season in full swing on both sides of the Atlantic, we prepare for the results from the engine room of the UK economy. The Banking Sector is not just one of the most popular on the London Stock Exchange, but is also a key barometer for the UK economy, impacting both markets and…

This year continues to provide surprise after surprise for foreign exchange markets to digest. Just when markets thought that major European elections were over, a snap UK election provided the latest global political shock, continuing the trend of the past twelve months. And now, with the fallout from the election yet to take its final…